Antibodies used in this study were as follows: anti-DYKDDDDK (anti-Flag) antibody (Trans Genic, Kobe, Japan), anti-SMα−actin, anti-α−tubulin antibodies, and anti-Flag M2 affinity gel (Sigma, St. Louis, MO), anti-myoD and anti-myogenin antibodies (Santa Cruz Biotechnology, Santa Cruz, CA), anti-myosin heavy chain (MHC) antibody (MF20) (Developmental Studies Hybridoma Bank), and Alexa 568-conjugated secondary antibody (Molecular Probes, Eugene, OR). Concerning a polyclonal anti-MRTF-A antibody, we described in detail previously [13 (link)]. Detail information about the plasmids used in this study was described elsewhere [8 (link), 22 (link)].
Free full text: Click here